Insider Transactions in Q4 2022 at Azenta, Inc. (AZTA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2022
|
Kimberly Crowley SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,519
+25.86%
|
-
|
|
Nov 17
2022
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
3,148
+3.3%
|
-
|
|
Nov 17
2022
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
3,778
+3.65%
|
-
|
|
Nov 17
2022
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,296
+5.1%
|
-
|
|
Nov 17
2022
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,886
+4.3%
|
-
|
|
Nov 17
2022
|
Vandana Sriram SVP Finance & Corp. Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,519
+29.61%
|
-
|
|
Nov 17
2022
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
3,778
+10.49%
|
-
|
|
Nov 17
2022
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
1,889
+18.2%
|
-
|
|
Nov 17
2022
|
Mitchell Coyne SVP and GM, Life Sciences Proj |
BUY
Grant, award, or other acquisition
|
Direct |
1,889
+50.0%
|
-
|
|
Nov 15
2022
|
Kimberly Crowley SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
574
-10.88%
|
-
|
|
Nov 15
2022
|
David C Gray Chief Strategy & New Business |
SELL
Payment of exercise price or tax liability
|
Direct |
5,235
-5.55%
|
-
|
|
Nov 15
2022
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
10,200
+9.76%
|
-
|
|
Nov 15
2022
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,535
-4.51%
|
-
|
|
Nov 15
2022
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
10,687
+9.61%
|
-
|
|
Nov 15
2022
|
Lindon G Robertson EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,091
-8.34%
|
-
|
|
Nov 15
2022
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,403
+14.43%
|
-
|
|
Nov 15
2022
|
Stephen S Schwartz CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,293
-6.14%
|
-
|
|
Nov 15
2022
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
48,580
+10.19%
|
-
|
|
Nov 15
2022
|
Vandana Sriram SVP Finance & Corp. Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
81
-2.28%
|
-
|
|
Nov 15
2022
|
Robin Vacha SVP, GM Life Science Products |
SELL
Payment of exercise price or tax liability
|
Direct |
5,838
-17.02%
|
-
|
|
Nov 15
2022
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
11,077
+24.41%
|
-
|
|
Nov 15
2022
|
Ginger Zhou SVP and General Manager, Genom |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-9.34%
|
-
|
|
Nov 15
2022
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
2,236
+23.49%
|
-
|